Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GSH-Responsive Metal-Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.

Small (Weinheim an der Bergstrasse, Germany)·2022
Same author

A Novel Technique Combining Human Acellular Dermal Matrix (HADM) and Enriched Platelet Therapy (EPT) for the Treatment of Vaginal Laxity: A Single-Arm, Observational Study.

Aesthetic plastic surgery·2022
Same author

Aggregation, solubility and cadmium-adsorption capacity of CuO nanoparticles in aquatic environments: Effects of pH, natural organic matter and component addition sequence.

Journal of environmental management·2022
Same author

Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer.

Expert review of pharmacoeconomics & outcomes research·2022
Same author

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.

Frontiers in surgery·2022
Same author

The Mechanism Study of Common Flavonoids on Antiglioma Based on Network Pharmacology and Molecular Docking.

Evidence-based complementary and alternative medicine : eCAM·2022
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.9K

Defect-engineered metal-organic framework as a universal platform for theranostic applications.

Shuguang Yang1, Xiaohong Xiong2, Qiyu Zhong3

  • 1Nanomedicine Research Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, PR China; Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, PR China.

Biomaterials
|April 25, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel functionalized metal-organic framework (Fun-MOF) for precise cancer treatment. This nanocarrier system delivers multiple drugs, combines photothermal/photodynamic therapies, and offers dual-modal imaging for advanced theranostics.

Keywords:
Bis–COOH–ICGDefect-engineeredHierarchically porous architectureMetal-organic frameworksMultidrug combinations

More Related Videos

Synthesis and Characterization of Functionalized Metal-organic Frameworks
11:27

Synthesis and Characterization of Functionalized Metal-organic Frameworks

Published on: September 5, 2014

48.1K
Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange
04:51

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange

Published on: June 23, 2023

3.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.9K
Synthesis and Characterization of Functionalized Metal-organic Frameworks
11:27

Synthesis and Characterization of Functionalized Metal-organic Frameworks

Published on: September 5, 2014

48.1K
Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange
04:51

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange

Published on: June 23, 2023

3.9K

Area of Science:

  • Nanomedicine
  • Materials Science
  • Oncology

Background:

  • Designing nanocarriers for multidrug co-delivery to combat complex disease microenvironments is a significant challenge in precision nanomedicine.
  • Existing nanocarriers often struggle with efficient drug loading and targeted delivery for combination therapies.

Purpose of the Study:

  • To develop a defect-engineered, functionalized metal-organic framework (Fun-MOF) for synergistic tumor photothermal/photodynamic therapy (PTT/PDT) and dual-modal imaging (PAI/FI).
  • To create a versatile platform for co-delivering specific drugs and therapeutic agents to remodel the tumor microenvironment.

Main Methods:

  • Synthesized a hierarchical micro/mesoporous Fun-MOF using dicarboxyl-functionalized indocyanine green (Bis-COOH-ICG) and Zr6 clusters.
  • Co-encapsulated HSP90 inhibitor 17-AAG and catalase (CAT) within the Fun-MOF structure.
  • Utilized the Fun-MOF for combined PTT/PDT and photoacoustic/fluorescence imaging (PAI/FI).

Main Results:

  • The hierarchical Fun-MOF demonstrated efficient co-encapsulation and synergistic antitumor effects by inhibiting HSP90 and scavenging hydrogen peroxide.
  • The Fun-MOF successfully remodeled the hypoxic tumor microenvironment, enhancing therapeutic efficacy.
  • The defective Fun-MOF platform showed potential for incorporating other carboxyl-containing therapeutics, indicating broad theranostic applicability.

Conclusions:

  • The developed defect-engineered Fun-MOF serves as an effective nanocarrier for multidrug co-delivery, PTT/PDT, and dual-modal imaging.
  • This platform offers a promising strategy for overcoming challenges in tumor microenvironment modulation and advancing precision nanomedicine.
  • The universal design facilitates the integration of diverse small-molecule therapeutics for versatile theranostic applications.